IP Library Granted Patent US 11,981,578
Granted Patent B2
US 11,981,578 · App. 16/839,570 · Granted May 14, 2024

Inhibited hydrofluoric acid composition

Inventors: Clay Purdy (Medicine Hat, CA); Markus Weissenberger (Calgary, CA); Karl W. Dawson (Calgary, CA); Kyle G. Wynnyk (Calgary, CA)
Assignee: Dorf Ketal Chemicals FZE
C01B7/191C03C15/02
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,981,578
App. No.
16/839,570
Granted
May 14, 2024
Kind
B2
Abstract

An inhibited hydrofluoric acid aqueous composition, said composition comprising: hydrofluoric acid in solution; and an alkanolamine; wherein said alkanolamine and hydrofluoric acid are present in a molar ratio of at least 1:1.

Claims (11)

1. A method of preparing an inhibited hydrofluoric acid composition, the inhibited hydrofluoric acid composition consisting of an aqueous solution of hydrofluoric acid and one or more alkanolamines, the method comprising:

adding one or more alkanolamines into a solution of hydrofluoric acid until the molar ratio of alkanolamine:hydrofluoric acid is at least 1.1:1,

wherein the prepared inhibited hydrofluoric acid composition has a pH ranging from 11.15 to 12.

2. The method of claim 1 , wherein the one or more alkanolamines is selected from the group consisting of monoethanolamine; diethanolamine; triethanolamine and combinations thereof.

3. The method of claim 1 , wherein the one or more alkanolamines is monoethanolamine.

4. The method of claim 3 , wherein the prepared inhibited hydrofluoric acid composition exhibits an acute dermal toxicity LD50 or greater than 5,050 mg/kg.

5. The method of claim 3 , wherein the prepared inhibited hydrofluoric acid composition is non-corrosive to an intact skin after four hours of exposure to the intact skin.

6. The method of claim 3 , wherein the prepared inhibited hydrofluoric acid composition exhibits a Primary Irritation Index (PII) of 0.4 after four hours of exposure to intact skin based on 1 hour, 24 hour, 48, hour and 72 hour observations of the exposed intact skin.

7. The method of claim 1 , wherein the one or more alkanolamines is diethanolamine.

8. The method of claim 1 , wherein the one or more alkanolamines is triethanolamine.

9. The method of claim 1 , wherein the solution of hydrofluoric acid consists of hydrogen fluoride and water.

Assignments (4)
SECURITY INTEREST Recorded Dec 12, 2023
From: DORF KETAL CHEMICALS FZE
To: HSBC BANK MIDDLE EAST LIMITED
Reel/Frame 065878/0104 →
CORRECTIVE ASSIGNMENT TO CORRECT THE PRIOR ERRONEOUS RECORDATION OF ASSIGNMENT APPLICATION NUMBERS: 15614284, 17148881 PREVIOUSLY RECORDED ON REEL 063118 FRAME 0689. ASSIGNOR(S) HEREBY CONFIRMS THE ASSIGNMENT. Recorded May 17, 2023
From: FLUID ENERGY GROUP LTD.
To: DORF KETAL CHEMICALS FZE
Reel/Frame 063695/0522 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 20, 2023
From: FLUID ENERGY GROUP LTD.
To: DORF KETAL CHEMICALS FZE
Reel/Frame 063118/0689 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 3, 2020
From: PURDY, CLAY; WEISSENBERGER, MARKUS; DAWSON, KARL W.; WYNNYK, KYLE G.
To: FLUID ENERGY GROUP LTD.
Reel/Frame 052306/0387 →
Priority Claims (1)
CA CA 3039238 · Apr 5, 2019 · national
Continuity (1)
Related Publication 20200317516A1 · Oct 8, 2020